(Total Views: 621)
Posted On: 05/16/2024 10:30:32 PM
Post# of 157731
I guess I’ll just say it. No I believe Merck is our partner. The CRC trial combined added HIV info kinda gave it away.
Not sure why they haven’t just said it yet.
https://www.biopharmadive.com/news/merck-deal...is/706309/
“The company is also developing combination formulations that pair Keytruda with other immunotherapies aimed at different cellular targets.“
As I had to point out once already today. Leronlimab is an immunotherapy!
Merck I’ll take 115 billon yesterday let’s get this show on the road.
Oh wait you said 15 billon. I guess we shall see.
Not sure why they haven’t just said it yet.
https://www.biopharmadive.com/news/merck-deal...is/706309/
“The company is also developing combination formulations that pair Keytruda with other immunotherapies aimed at different cellular targets.“
As I had to point out once already today. Leronlimab is an immunotherapy!
Merck I’ll take 115 billon yesterday let’s get this show on the road.
Oh wait you said 15 billon. I guess we shall see.
(7)
(0)
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
— Jeremiah 51:36
